Regulatory Work to Secure Licence Variation for anastrozole

A Tender Notice
by NHS ENGLAND

Source
Find a Tender
Type
Contract (Services)
Duration
1 year
Value
£1
Sector
HEALTH
Published
23 Dec 2021
Delivery
01 Apr 2022 to 31 Mar 2023
Deadline
31 Jan 2022 13:00

Concepts

Location

United Kingdom:

Geochart for 1 buyers and 0 suppliers

1 buyer

Description

This Tender is solely for the work involved to apply for and implement a major (type II) MHRA Marketing Authorisation variation to add a new clinical indication for anastrozole. The successful Bidder will be responsible for ensuring that all relevant MHRA conditions and documentation for the Marketing Authorisation variation are met and submitted within the time limits agreed with the Authority.

Total Quantity or Scope

In return the Authority will fund actual and reasonably incurred costs associated with obtaining this licence variation only.

CPV Codes

  • 85149000 - Pharmacy services
  • 33600000 - Pharmaceutical products

Indicators

  • This is a one-off contract (no recurrence)
  • Renewals are not available.
  • Professional qualifications are sought.

Other Information

In return the Authority will fund actual and reasonably incurred costs associated with obtaining this licence variation only.Full details can be found on the Atamis portal: https://health-family.force.com/s/Welcome Closing date for submissions is 31st January 2022 at 13:00 ** PREVIEW NOTICE, please check Find a Tender for full details. **

Reference

Domains